Director, Nonclinical Development

Job Description
The Position The Director, Nonclinical Development is responsible for providing nonclinical subject matter expertise to support programs in Organon’s portfolio of products across Women’s Health, General Medicines, and Biosimilars. This position will report to the Executive Director, Translational Sciences and Nonclinical Development and work collaboratively with early clinical development, late-clinical development, regulatory affairs, safety and pharmacovigilance, chemistry, manufacturing and control (CMC), medical affairs and business development as necessary.

To that aim, this position will serve as the nonclinical representative on asset development teams (ADTs) to support life‑cycle management of products in Organon’s portfolio. This position will also be responsible for contributing to, and reviewing, nonclinical modules for regional regulatory submissions and renewals for global submissions. Additionally, author and review briefing books, investigator brochures, and other regulatory documents as applicable.

This position will also support toxicological risk assessments associated with CMC activities.

• Serve as the Nonclinical representative on ADTs in the development and execution of life-cycle management activities for products in Organon’s portfolio.
• Author and review of nonclinical CTD modules, briefing books, or other regulatory communications for regional regulatory submissions or renewals for global products within the Organon portfolio.
• Nonclinical point of contact for Regulatory, Safety, and Pharmacovigilance activities support of the Organon Women’s Health, General Medicines and Biosimilars product portfolio.
• Nonclinical toxicology liaison with CMC and Occupational Safety to conduct risk assessments to inform mitigation strategies in accordance with regional and/or global regulatory requirements. Collaborate with CMC to assess process manufacturing impurities, degradants, and/or extraneous matters and conduct risk assessments to inform mitigation strategies in accordance with regional and/or global regulatory requirements.
• Provide scientific and nonclinical input (toxicology, pharmacology, DMPK) for Organon products and ADTs.
• Prepare, contribute to and/or review the nonclinical or CMC documentation to support regulatory submissions to regional Health Authorities worldwide; may participate in interactions with Health Authorities.
• Support Regulatory activities for global products such as, annual reporting of nonclinical activities and literature, support new regional drug applications, regional license renewals, author responses to questions from global Heath Authorities.
• Support Drug Safety and Pharmacovigilance with activities such as review of nonclinical literature for new risks, signal evaluation for issues identified through pharmacovigilance or communications through Health Authorities, and author responses to regulatory inquiries as appropriate.
• Contribute to regional or global product label reviews and updates as appropriate.
• Collaborate with CMC and Occupational Safety to evaluate process manufacturing impurities and/or degradants and conduct risk assessments to inform mitigation strategies in accordance with regional and/or global regulatory requirements. Provide nonclinical support for occupational and environmental risk assessments.
• Support the established product portfolio in line with Good Laboratory Practices (GLP), Good Clinical Practice (GCP) and relevant Organon Standard Operating Procedures (SOPs).

• PhD, DVM or equivalent degree in pharmacology, biology, physiology, biochemistry, chemistry, toxicology or related sciences.
• Board certification in toxicology a plus (e.g., DABT, ERT).
• A minimum of 10 years of experience in the pharmaceutical or biotech industry with extensive and in-depth knowledge across nonclinical disciplines in context of drug development, including toxicology, DMPK and pharmacology.
• Demonstrated technical and scientific knowledge in nonclinical sciences with a particular emphasis on supporting late-stage drug development and life-cycle management.
• Demonstrated knowledge of nonclinical…